Pharmacogenomic Product definition

Pharmacogenomic Product means a product that is primarily used to select between two or more therapeutic or prophylactic regimens for a human, wherein at least one such therapeutic or prophylactic regimen involves a compound that could be used to treat and/or prevent a disease, and where the selected regimen is judged based on the use of the pharmacogenomic product to be of most likely benefit and/or to do the least harm to a patient, and provided that such selection is made based on the genotype of such human at certain genetic loci (including by detection of certain protein products indicative of the necessary genotype) as determined by use of such product to detect either (i) sequence differences in different alleles of a Mammalian Target, or (ii) the presence or absence of a certain Mammalian Target, or (iii) the presence or absence of the protein product of a certain Mammalian Target.
Sample 1Sample 2Sample 3
Pharmacogenomic Product means [ * ].
Sample 1Sample 2Sample 3
Pharmacogenomic Product means a product that is primarily used to select between two or more therapeutic or prophylactic regimens for a human, wherein at least one such therapeutic or prophylactic regimen involves a compound that could be used to treat and/or prevent a disease, and where the selected regimen is judged based on the use of the pharmacogenomic product to be of most likely benefit and/or to do the least harm to a patient, and provided that such selection is made based on the genotype of such human at certain genetic loci (including by detection of certain protein products indicative of the necessary genotype) as determined by use of such product to detect either
Sample 1Sample 2

Examples of Pharmacogenomic Product in a sentence

  • For each Pharmacogenomic Product that is based upon the detection of [ * ] of, a Novel Target, BMS shall pay Exelixis a royalty equal to [ * ] of the Net Sales of each such Pharmacogenomic Product.

  • For each Diagnostic Product that is based upon the detection of [ * ] of, an Unlinked Related Target, BMS shall pay Exelixis a royalty equal to [ * ] of the Net Sales of each such Pharmacogenomic Product.

  • BMS shall pay royalties to Exelixis at the rate of [ * ] of Net Sales of each Pharmacogenomic Product.

  • For clarity, it is understood and agreed that the Net Sales of a particular Diagnostic Product or Pharmacogenomic Product that is a Multiple Marker Product shall not be adjusted by the adjustment mechanism set forth in Section 1.43 for "combined products".

  • Such license for a particular Pharmacogenomic Product shall be sublicensable solely (x) together with a sublicense under Section 5.1(a)(ii) with respect to a related BMS Product or (y) by BMS or its sublicensee, for the purpose of developing or commercializing a Pharmacogenomic Product for use in conjunction with a related BMS Product that BMS or its sublicensee is developing or commercializing.

  • Such license for a particular Pharmacogenomic Product shall be sublicensable solely (x) together with a sublicense under Section 5.3(b) with respect to a related EXEL Product or (y) by Exelixis or its sublicensee, for the purpose of developing or commercializing a Pharmacogenomic Product for use in conjunction with a related EXEL Product that Exelixis or its sublicensee is developing or commercializing.

  • The Parties contemplate that, from time to time during the Program Term, either Party may wish to undertake a project relating to the research and development of a Pharmacogenomic Product in colon cancer (a "Colon PGX Project").

  • A Party's obligation to pay royalties under Section 4.2 is imposed only once with respect to the same unit of Program Product or Third Party Pharmacogenomic Product.

  • Notwithstanding the foregoing, in the event any license granted hereunder by BD relating to any Exclusive Product Area or Co-Exclusive Non-Colon Pharmacogenomic Product Opportunity is terminated or converted to non-exclusive pursuant to Sections 2.7 or 2.9, in either case with respect to the Territory or a Major Market, then [*****].

  • With respect to each sale of each Third Party Pharmacogenomic Product by Becton Dickxxxxx, xxs Affiliates or Approved Sublicensees, Becton Dickxxxxx xxxll pay to MPMx a royalty of (i) [**] Confidential Materials omitted and filed separately with the Securities and Exchange Commission.


More Definitions of Pharmacogenomic Product

Pharmacogenomic Product means any Kit that contains one or more Validated Markers, and (a) is used to [**]. The term "Pharmacogenomic Product" includes both Home Brew Products and products that have received regulatory review and/or approval.
Sample 1
Pharmacogenomic Product means any product, service or test, other than a Diagnostic Product, that is at any stage of discovery, development, research, manufacture or commercialization and which (a) is intended for use in the clinical development, marketing or prescription of a Therapeutic Product and (b) detects directly or indirectly (i) one or more Polymorphisms or Haplotype Markers in a Marker Association or (ii) one or more Surrogate Markers of such Polymorphisms or Haplotype Markers in a Marker Association.
Sample 1

Related to Pharmacogenomic Product

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Licensed Compound means [***].

  • Royalty Product means, either (a) an Alnylam Royalty Product, or (b) an Inex Royalty Product.

  • cosmetic product means any substance or mixture intended to be placed in contact with the external parts of the human body (epi­ dermis, hair system, nails, lips and external genital organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their appearance, protecting them, keeping them in good condition or correcting body odours;

  • Generic Product means a product which (a) contains as its active pharmaceutical ingredient a compound that is (or is substantially the same as) the Licensed Compound, and (b) has been placed on the market pursuant to a validly granted marketing authorization.

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Marihuana-infused product means a topical formulation, tincture, beverage, edible substance, or similar product containing marihuana and other ingredients and that is intended for human consumption.

  • Cannabis product means cannabis that has undergone a process whereby the plant material has been transformed into a concentrate, including, but not limited to, concentrated cannabis, or an edible or topical product containing cannabis or concentrated cannabis and other ingredients.

  • Hemp products means all products made from industrial hemp,

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Therapeutic school means a residential group living facility:

  • complex product means a product which is composed of multiple components which can be replaced permitting disassembly and re-assembly of the product.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.